Follow
Michael Cole
Michael Cole
Verified email at newcastle.ac.uk
Title
Cited by
Cited by
Year
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
J Dyson, B Jaques, D Chattopadyhay, R Lochan, J Graham, D Das, ...
Journal of hepatology 60 (1), 110-117, 2014
6552014
Human renal function maturation: a quantitative description using weight and postmenstrual age
MM Rhodin, BJ Anderson, AM Peters, MG Coulthard, B Wilkins, M Cole, ...
Pediatric nephrology 24 (1), 67-76, 2009
4932009
Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide
J Bray, J Sludden, MJ Griffin, M Cole, M Verrill, D Jamieson, AV Boddy
British journal of cancer 102 (6), 1003-1009, 2010
2012010
High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma
J Carr-Wilkinson, K O'Toole, KM Wood, CC Challen, AG Baker, JR Board, ...
Clinical cancer research 16 (4), 1108-1118, 2010
1962010
Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas
CS McManamy, JM Lamont, RE Taylor, M Cole, ADJ Pearson, SC Clifford, ...
Journal of Neuropathology & Experimental Neurology 62 (6), 627-632, 2003
1422003
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors
R Skinner, A Parry, L Price, M Cole, AW Craft, ADJ Pearson
European journal of cancer 45 (18), 3213-3219, 2009
1352009
p53 cellular localization and function in neuroblastoma: evidence for defective G1 arrest despite WAF1 induction in MYCN-amplified cells
DA Tweddle, AJ Malcolm, M Cole, ADJ Pearson, J Lunec
The American journal of pathology 158 (6), 2067-2077, 2001
1332001
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma
SL Ryan, EC Schwalbe, M Cole, Y Lu, ME Lusher, H Megahed, K O’Toole, ...
Acta neuropathologica 123, 501-513, 2012
1112012
Rapid diagnosis of medulloblastoma molecular subgroups
EC Schwalbe, JC Lindsey, D Straughton, TL Hogg, M Cole, H Megahed, ...
Clinical cancer research 17 (7), 1883-1894, 2011
1032011
Poly (ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines
T Zaremba, P Ketzer, M Cole, S Coulthard, ER Plummer, NJ Curtin
British journal of cancer 101 (2), 256-262, 2009
1032009
Cyclophosphamide pharmacokinetics in children.
SM Yule, AV Boddy, M Cole, L Price, R Wyllie, MJ Tasso, AD Pearson, ...
British journal of clinical pharmacology 41 (1), 13-19, 1996
1001996
Expression of µ Class Glutathione S-Transferase Correlates with Event-free Survival in Childhood Acute Lymphoblastic Leukemia
AG Hall, P Autzen, AR Cattan, AJ Malcolm, M Cole, J Kernahan, MM Reid
Cancer Research 54 (20), 5251-5254, 1994
931994
Neonatal vitamin K administration and childhood cancer in the north of England: retrospective case-control study
L Parker, M Cole, AW Craft, EN Hey
Bmj 316 (7126), 189-193, 1998
891998
Cyclophosphamide metabolism in children
S Murray Yule, AV Boddy, M Cole, L Price, R Wyllie, MJ Tasso, ...
Cancer Research 55 (4), 803-809, 1995
891995
Poly (ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers
T Zaremba, HD Thomas, M Cole, SA Coulthard, ER Plummer, NJ Curtin
Biochemical Journal 436 (3), 671-679, 2011
852011
The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion
AV Boddy, M Cole, ADJ Pearson, JR Idle
Cancer chemotherapy and pharmacology 36, 53-60, 1995
721995
Screening for Wilms' tumour in patients with aniridia, Beckwith syndrome, or hemihypertrophy
AW Craft, L Parker, C Stiller, MC Msc
Medical and pediatric oncology 24 (4), 231-234, 1995
691995
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study
GJ Veal, M Cole, J Errington, A Parry, J Hale, ADJ Pearson, K Howe, ...
Clinical cancer research 11 (16), 5893-5899, 2005
682005
Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose
R Skinner, A Parry, L Price, M Cole, AW Craft, ADJ Pearson
Pediatric blood & cancer 54 (7), 983-989, 2010
652010
The effect of fluconazole on cyclophosphamide metabolism in children
SM Yule, D Walker, M Cole, L McSorley, S Cholerton, AK Daly, ...
Drug metabolism and disposition 27 (3), 417-421, 1999
601999
The system can't perform the operation now. Try again later.
Articles 1–20